Abiraterone acetate and prednisolone are recommended to be available as a routine commissioning treatment option for high-risk, hormone sensitive, non-metastatic prostate cancer (newly diagnosed ...
To create instances of 'managed' objects Gradle uses ASM to generate subtypes, and additionally creates inner classes to instantiate new instances. I think these non-static classes might be causing ...
XTANDI: the first and only androgen receptor inhibitor-based regimen to demonstrate overall survival benefit in non-metastatic hormone-sensitive prostate cancer (nmHSPC) with high-risk biochemical ...
While the ductal subtype accounts for 70% to 80% of all breast cancers and the lobular subtype accounts for just 10% to 15%, the lobular subtype is more common among peri- and postmenopausal women, is ...
Community driven content discussing all aspects of software development from DevOps to design patterns. Instance main methods and unnamed classes, coming in Java 21, will forever change how developers ...
Four days ahead of its July 7 PDUFA date, the U.S. FDA granted accelerated approval to Dizal (Jiangsu) Pharmaceutical Co. Ltd.’s sunvozertinib (DZD-9008), branded as Zegfrovy, for treating adults with ...
The U.S. Food and Drug Administration (FDA) has granted Fast Track designation to BBO-8520 for the treatment of adult patients with previously treated, KRAS G12C-mutated metastatic non-small cell lung ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved ensartinib for the treatment of certain patients with ALK-positive locally advanced or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results